Organogenesis Holdings (ORGO) Return on Capital Employed (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Return on Capital Employed of 0.53% for Q1 2026, up 632.0% year-over-year from 0.07% in Q1 2025, and down 94.64% quarter-over-quarter from 9.84% in Q4 2025.
Organogenesis Holdings (ORGO) Return on Capital Employed (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Return on Capital Employed history runs 10 years deep, the most recent figure standing at 0.53% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 632.0% year-over-year to 0.53%; the TTM figure through Mar 2026 stood at 0.53% (up 632.0% YoY), while the FY2025 annual figure was 9.97%, up 1029.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 0.53%, down from 9.84% in the prior quarter.
- The five-year high for Return on Capital Employed was 16.46% in Q1 2022, with the low at 5.79% in Q1 2025.
- The 5-year median for Return on Capital Employed is 3.37% (2024), against an average of 3.33%.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed sank 1852 bps in 2022, then soared 1017 bps in 2025.
- Organogenesis Holdings' Return on Capital Employed stood at 5.9% in 2022, then slumped by 44 bps to 3.29% in 2023, then plunged by 110 bps to 0.33% in 2024, then surged by 3127 bps to 9.84% in 2025, then slumped by 95 bps to 0.53% in 2026.
- Business Quant data shows ORGO's Return on Capital Employed at 0.53% in Q1 2026, 9.84% in Q4 2025, and 2.12% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | -8.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.83% |
| Mar 31, 2026 | 0.53% |
| Dec 31, 2025 | 9.84% |
| Sep 30, 2025 | -2.12% |
| Jun 30, 2025 | -5.74% |
| Mar 31, 2025 | -5.79% |
| Dec 31, 2024 | -0.33% |
| Sep 30, 2024 | -3.48% |
| Jun 30, 2024 | -3.00% |
| Mar 31, 2024 | 3.37% |
| Dec 31, 2023 | 3.29% |
| Sep 30, 2023 | 6.00% |
| Jun 30, 2023 | 4.33% |
| Mar 31, 2023 | 4.96% |
| Dec 31, 2022 | 5.90% |
| Sep 30, 2022 | 9.07% |
| Jun 30, 2022 | 13.35% |
| Mar 31, 2022 | 16.46% |
| Dec 31, 2021 | 22.28% |
| Sep 30, 2021 | 26.26% |